RT journal article
T1 Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction
A1 Morales-Ponce, Francisco J.
A1 González Pérez, Pablo José
A1 Blasco-Turrión, Sara
A1 Sánchez-Brotons, Juan Antonio
A1 Collado-Moreno, Carmen
A1 Martínez-Romero, Pedro
A1 Martínez-Morentín, Eduardo
A1 Caro-Mateo, Pilar
A2 Medicina
AB Adjunctive medical therapy during primarypercutaneous coronary intervention (PPCI) isbased on anticoagulation and antiplatelet drugs. Additionally,the glycoprotein IIb/IIIa inhibitor (GPI)abciximab has been shown to reduce infarct size insome clinical trials [1]. However, the role of intracoronaryfibrinolysis has not been well establishedduring PPCI. We sought to explore the hypothesisthat a locally administered fibrinolytic could bemore effective in dissolving coronary thrombusat the macro and microvasculature than addinga third antiplatelet drug in patients already receivingdouble antiplatelet therapy, and therefore improvemyocardial perfusion and left ventricular function.
PB VIA MEDICA
SN 1897-5593
YR 2021
FD 2021-01
LK http://hdl.handle.net/10498/24794
UL http://hdl.handle.net/10498/24794
LA eng
DS Repositorio Institucional de la Universidad de Cádiz
RD 10-nov-2026